You have 9 free searches left this month | for more free features.

modified FOLFOX

Showing 1 - 25 of 4,952

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Adenocarcinoma of the Stomach, GastroEsophageal Cancer Trial in Germany (Nivolumab, Ipilimumab, mFOLFOX)

Active, not recruiting
  • Adenocarcinoma of the Stomach
  • GastroEsophageal Cancer
  • Amberg, Germany
  • +26 more
Jan 12, 2023

Colorectal Cancer Trial in Paris (FOLFOX regimen, fluorouracil, leucovorin calcium)

Active, not recruiting
  • Colorectal Cancer
  • FOLFOX regimen
  • +5 more
  • Paris, France
    GERCOR Groupe Cooperateur Multidisciplinaire en Oncologie
Jan 20, 2022

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in

Completed
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +3 more
  • metformin hydrochloride
  • +4 more
  • Cleveland, Ohio
  • +1 more
Aug 9, 2021

Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Gastric Cardia Trial in

Active, not recruiting
  • Adenocarcinoma of the Esophagus
  • +5 more
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jul 25, 2022

Metastatic Pancreatic Adenocarcinoma Trial in Madrid (nab-paclitaxel, gemcitabine, m-FOLFOX)

Completed
  • Metastatic Pancreatic Adenocarcinoma
  • Madrid, Spain
    Spanish Cooperative for Digestive Tumour Therapy (TTD)
Aug 11, 2021

Hepatocellular Carcinoma Stage IIIa Trial in Hangzhou (Lenvatinib, mFOLFOX regimen, ROX regimen)

Enrolling by invitation
  • Hepatocellular Carcinoma Stage IIIa
  • Hangzhou, Zhejiang, China
    The Cancer Hospital of the University of Chinese Academy of Scie
Aug 12, 2021

Advanced Solid Tumors, Colorectal Cancer, Non Small Cell Lung Cancer Trial in France, Spain (CAN04 (nadunolimab), mFOLFOX, DTX)

Active, not recruiting
  • Advanced Solid Tumors
  • +3 more
  • CAN04 (nadunolimab)
  • +3 more
  • Saint-Herblain, Boulevard Jacques Monod, France
  • +5 more
Oct 20, 2022

Mucinous Adenocarcinoma of the Rectum, Signet Ring Adenocarcinoma of the Rectum, Stage IIA Rectal Cancer Trial in Los Angeles

Active, not recruiting
  • Mucinous Adenocarcinoma of the Rectum
  • +7 more
  • bevacizumab
  • +4 more
  • Los Angeles, California
    USC Norris Comprehensive Cancer Center
Aug 5, 2022

Unresectable Adenocarcinoma of the Esophagus, Metastatic Adenocarcinoma of the Esophagus, Unresectable Adenocarcinoma of Gastric

Completed
  • Unresectable Adenocarcinoma of the Esophagus
  • +3 more
  • Los Angeles, California
  • +1 more
Sep 3, 2021

HER2 Positive Advanced/Metastatic/Nonresectable Biliary Tract Cancer Trial in Seoul (HERZUMA+mFOLFOX)

Recruiting
  • HER2 Positive Advanced/Metastatic/Nonresectable Biliary Tract Cancer
  • Seoul, Korea, Republic of
    Division of Medical Oncology, Yonsei Cancer Center, Yonsei Univ.
Jan 19, 2021

Colon Cancer Trial in United States (Bevacizumab, Cetuximab, 5-fluorouracil)

Completed
  • Colon Cancer
  • Evansville, Indiana
  • +9 more
Dec 14, 2021

Colo-rectal Cancer Trial in Beijing (Experimental: mXELOX plus cetuximab, Active Comparator: FOLFOX plus cetuximab)

Recruiting
  • Colo-rectal Cancer
  • Experimental: mXELOX plus cetuximab
  • Active Comparator: FOLFOX plus cetuximab
  • Beijing, China
    Cancer Hospital & Institute, Chinese Academy of Medical Sciences
Sep 29, 2021

Advanced Gastrointestinal (GI) Malignancies, Hepatocellular Carcinoma, Gastric Cancer Trial in Worldwide (ADI-PEG 20 plus

Terminated
  • Advanced Gastrointestinal (GI) Malignancies
  • +3 more
  • ADI-PEG 20 plus modified FOLFOX6
  • San Francisco, California
  • +34 more
Apr 18, 2022

Metastatic Pancreatic Cancer Trial in Washington (ABT-888 and mFOLFOX-6)

Unknown status
  • Metastatic Pancreatic Cancer
  • ABT-888 and mFOLFOX-6
  • Washington, District of Columbia
    Georgetown Lombardi Comprehensive Cancer Center
Mar 2, 2020

Hepatocellular Cancer Trial in Boston (Leucovorin, Fluorouracil, Oxaliplatin)

Completed
  • Hepatocellular Cancer
  • Boston, Massachusetts
  • +2 more
Apr 21, 2020

Advanced Solid Tumors, Carcinoid, Colorectal Cancer Trial in Poland, Spain, United States (Modified FOLFOX6, Conatumumab,

Completed
  • Advanced Solid Tumors
  • +8 more
  • Modified FOLFOX6
  • +3 more
  • Duarte, California
  • +11 more
Feb 3, 2021

Gastric Cancer Trial in Worldwide (Bemarituzumab, Placebo, Modified FOLFOX6)

Completed
  • Gastric Cancer
  • Bemarituzumab
  • +2 more
  • Tucson, Arizona
  • +188 more
Dec 15, 2022

Neuropathy;Peripheral Trial in Tanta (Placebo tablets, Ketotifen Oral Tablet)

Not yet recruiting
  • Neuropathy;Peripheral
  • Placebo tablets
  • Ketotifen Oral Tablet
  • Tanta, Egypt
    Tanta university
Nov 23, 2022

Colon Cancer Trial (mFOLFIRINOX-FOLFIRI intensified chemo, FOLFOX or CAPOX adjuvant chemo)

Not yet recruiting
  • Colon Cancer
  • mFOLFIRINOX-FOLFIRI intensified chemotherapy
  • FOLFOX or CAPOX adjuvant chemotherapy
  • (no location specified)
Sep 6, 2022

Adenocarcinoma Esophagus Trial in Milwaukee (Circulating tumor DNA(ctDNA) level measurement)

Recruiting
  • Adenocarcinoma Esophagus
  • Circulating tumor DNA(ctDNA) level measurement
  • Milwaukee, Wisconsin
    Froedtert Hospital and the Medical College of Wisconsin
May 23, 2022

Locally Advanced Rectal Carcinoma, Stage II Rectal Cancer AJCC v8, Stage III Rectal Cancer AJCC v8 Trial in Gainesville, New

Recruiting
  • Locally Advanced Rectal Carcinoma
  • +2 more
  • Gainesville, Florida
  • +1 more
Jan 4, 2023

Advanced Rectal Cancer Trial in Rochester (FOLFOX)

Active, not recruiting
  • Advanced Rectal Cancer
  • Rochester, New York
  • +1 more
Jun 9, 2022

Colorectal Cancer, Chemo-induced Peripheral Neuropathy Trial in Worldwide (Calmangafodipir (5 µmol/kg), Placebo)

Terminated
  • Colorectal Cancer
  • Chemotherapy-induced Peripheral Neuropathy
  • Calmangafodipir (5 µmol/kg)
  • Placebo
  • Aalst, Belgium
  • +64 more
Nov 19, 2021

Rectal Cancer Trial in Mecca (Chemotherapy)

Recruiting
  • Rectal Cancer
  • Mecca, Makkah Western, Saudi Arabia
    King Abdullah Medical City, Holy Capital
Apr 5, 2022